Newsroom
Sorted by: Latest
-
Sensorion annonce un financement de 60 millions d’euros incluant un investissement stratégique de Sanofi de 20 millions d’euros aux côtés de spécialistes mondiaux de la santé afin de faire progresser son portefeuille de produits de thérapie génique
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN), société pionnière de biotechnologie au stade clinique, spécialisée dans le développement de nouvelles thérapies pour restaurer, traiter et prévenir les troubles de la perte auditive, annonce aujourd'hui la réalisation d’une offre réservée à des catégories spécifiques d'investisseurs (l' « Offre Réservée ») d'un montant de 60 millions d'euros, à travers l'émission de 214 285 714 actions ordinaires nouvelles...
-
Sensorion Announces €60 Million Financing With a €20M Strategic Investment from Sanofi and Support from Global Healthcare Specialists To Advance Genetic Medicine Pipeline
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announced a €60 million offering reserved to specific categories of investors (the “Reserved Offering”) through the issuance of 214,285,714 new ordinary shares of the Company (the “New Shares”) at a price per New Share of €0.28 (the “Subscriptio...
-
WinDC and Megaport Partnership Announcement
SYDNEY--(BUSINESS WIRE)--WinDC today announced a strategic partnership with Megaport (ASX:MP1) that will connect WinDC’s renewable-powered AI Factories to Megaport’s global Network as a Service platform. The partnership enables high-density AI compute deployed at renewable generation sites to be accessed by organisations across Australia and throughout Megaport’s international network. WinDC’s model introduces a new category of AI infrastructure in the Australian market. Instead of building dat...
-
Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G pTau 217 CSF Assay for Research Use Only
GENT, Belgium & MALVERN, Pa. & TOKYO--(BUSINESS WIRE)--H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G pTau 217 CSF assay for the fully automated LUMIPULSE® G immunoassay analyzers. This CLEIA (chemiluminescent enzyme immunoassay) assay is available for Research Use Only (RUO) and allows for the quantitative measurement of Tau phosphorylated at threonine 217 (pTau 217) in human cerebrospinal fluid (CSF) within just 35 minute...
-
NTT, DOCOMO, and NTT DATA to Exhibit at MWC Barcelona 2026
TOKYO--(BUSINESS WIRE)--The NTT Group, comprising NTT, Inc., NTT DOCOMO, INC., and NTT DATA Group Corporation, announced today that they will jointly exhibit at MWC Barcelona 2026, the world’s largest connectivity event, to be held in Barcelona, Spain, from March 2 to March 5, 2026. At this event, the NTT Group will showcase its technological capabilities and foster deeper connections with leading global companies. Under the unified concept introduced following the corporate identity (CI) renew...
-
Thomas & Friends Unveils Refreshed Look and Logo, Full Steam Ahead Into the Next Era of a Beloved Global Brand
EL SEGUNDO, Calif.--(BUSINESS WIRE)--Thomas & Friends™ reveals a bold new look for Thomas the Tank Engine, kicking off a full-franchise relaunch rolling out this fall....
-
ZCG Consulting Real Estate Division Renegotiates Large-Scale Lease Portfolio for Sponsor-Held Portfolio Company
NEW YORK--(BUSINESS WIRE)--ZCG Consulting (“ZCGC”), the business consulting services platform of Z Capital Group (“ZCG”), through its Real Estate Division, today announced the successful renegotiation and restructuring of a large-scale industrial lease portfolio on behalf of a sponsor-held portfolio company. The engagement reduced long-dated lease exposure across the portfolio while maintaining uninterrupted operations at multiple operating facilities. The mandate encompassed a legacy lease por...
-
United States Drug Testing Laboratories (USDTL) and CourtFact Announce Integrated Partnership to Streamline Case Management and Drug Testing Services
DES PLAINES, Ill.--(BUSINESS WIRE)--United States Drug Testing Laboratories (USDTL), a national leader in forensic and clinical toxicology and mid- to long-term drug and alcohol testing, today announced a new integration partnership with CourtFact, a trusted client management platform widely used by justice-involved programs and service providers across the country. The collaboration brings USDTL’s comprehensive lab-based and instant testing solutions directly into the CourtFact system, enablin...
-
エアスパン、Space Compassと提携し、高高度海上監視に5G接続を導入
米テキサス州プラノ--(BUSINESS WIRE)--(ビジネスワイヤ) -- ワイヤレスネットワークソリューションの大手プロバイダーであるエアスパン・ネットワークス・ホールディングスLLC(「エアスパン」)は、Space Compassの高高度プラットフォーム ステーション(HAPS)向けに5G空対地(ATG)通信システムを導入し、成層圏からの新世代の海洋状況把握(MDA)を可能にする計画を発表しました。 このプロジェクトでは、高度16~18kmからの5G接続により、HAPS機体と最大300km離れた地上局の間でセキュアな指揮統制とリアルタイムのミッションデータを配信できることを実証します。 エアスパンの5G In-Motion ATG技術を活用したこのシステムは、高度なビームフォーミングとハイゲイン アンテナ システムにより、高速データレート、広域海上カバレッジ、そして360度連続接続を実現します。このユースケースは、従来のネットワークの到達範囲外にある天候に左右されない航路、沿岸地域、遠隔海域の継続的な監視をサポートするように設計されています。 このシステムには、航空機搭載無...
-
StandardAero Announces Pricing of Its Secondary Offering of 50,000,000 Shares of Common Stock by Affiliates of The Carlyle Group Inc. and GIC
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--StandardAero, Inc. (NYSE: SARO) (“StandardAero” or the “Company”) announced today the pricing of its underwritten public offering by two of its stockholders (the “Selling Stockholders”), affiliates of The Carlyle Group Inc. and GIC, of an aggregate of 50,000,000 shares of the Company’s common stock, par value $0.01 per share (“Common Stock”), at a price to the public of $31.00 per share. The Selling Stockholders will receive all of the net proceeds from this...